Finkelstein M M, Kreiger N
Ontario Ministry of Labour, Toronto, Canada.
Occup Environ Med. 1996 May;53(5):305-11. doi: 10.1136/oem.53.5.305.
Radium induces bone sarcomas at high doses, but there is controversy about risk at low doses. A previous study in Ontario found an association between the presence of radium in birthplace water supplies and an increased risk of death from bone cancer in young people. An investigation was performed to test the findings of the previous study with an independent group of subjects for whom complete information on radium exposure would be obtained.
A population based case-control study (238 cases; 432 controls) was conducted with incident cases of bone sarcoma identified from the Ontario cancer registry. Residential histories were collected by questionnaire and water samples were obtained and analysed for radium content.
There was an association between risk of osteosarcoma and birthplace exposures (odds ratios (ORs) and 90% confidence intervals (90% CIs) 1.77 (1.03-3.00) but not with lifetime measures of exposure. When lifetime exposure was dichotomised, the OR was 1.31 (0.76-2.24) for osteosarcoma. There was no trend with increasing exposure. Bootstrap resampling was used to simulate lifetime doses in a pooled analysis of 1293 subjects from the two Ontario studies. The ORs were 1.38 (1.08-1.73) for all sarcomas, and 1.44 (1.01-1.87) for osteosarcoma. Geometric mean doses in bone were about 26 mRad.
An association was found between the presence of radium in birthplace water supplies and increased risk of bone sarcoma in two studies. Increased risk was present for lifetime measures of exposure, but the association was not significant, and there was no dose-response trend. Our findings are compatible with the absence of risk at low doses, but they might also reflect inadequate statistical power to measure a true risk at environmental exposure levels. If the increased risk at environmental doses is causal, risk of bone sarcoma is effectively linearly related to dose over five orders of magnitude.
高剂量镭会诱发骨肉瘤,但低剂量时的风险存在争议。安大略省此前的一项研究发现,出生地水源中存在镭与年轻人骨癌死亡风险增加之间存在关联。开展了一项调查,以用一组独立受试者检验先前研究的结果,这些受试者能获得关于镭暴露的完整信息。
基于人群的病例对照研究(238例病例;432名对照),研究对象为从安大略癌症登记处确定的骨肉瘤新发病例。通过问卷调查收集居住史,并采集水样分析镭含量。
骨肉瘤风险与出生地暴露之间存在关联(优势比(OR)及90%置信区间(90%CI)为1.77(1.03 - 3.00)),但与终生暴露量无关。将终生暴露量进行二分法分析时,骨肉瘤的OR为1.31(0.76 - 2.24)。暴露量增加无明显趋势。在对安大略省两项研究的1293名受试者进行的汇总分析中,采用自助重抽样法模拟终生剂量。所有肉瘤的OR为1.38(1.08 - 1.73),骨肉瘤的OR为1.44(1.01 - 1.87)。骨骼中的几何平均剂量约为26毫拉德。
两项研究均发现出生地水源中存在镭与骨肉瘤风险增加之间存在关联。终生暴露量增加时也存在风险增加情况,但该关联不显著,且无剂量反应趋势。我们的研究结果与低剂量无风险的情况相符,但也可能反映出在环境暴露水平下测量真正风险的统计效力不足。如果环境剂量下的风险增加具有因果关系,那么骨肉瘤风险在五个数量级上与剂量有效呈线性相关。